Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Predicted deadline: Nov 3, 2023

Grant amount: Up to US $200,000

Funding uses: Research

Location of project: United States

Location of residency: United States

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

The goal of the NIAMS clinical trial program is to support research leading to the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. The purpose of the Exploratory Clinical Trials Grants Program is to foster clinical trials that will lead to clinically meaningful improvements in prevention, diagnosis, or treatment of these conditions or diseases.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.